UPDATED May 17, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IBNSINA | ৳247.40 | -2.1% | -13.7% | ৳7.7b | ৳390.00 | PE11.9x | E19.2% | 2.4% | Pharmaceuticals & Biotech |